08/25/2026
Moderna and Merck said a late-stage trial of a personalized cancer treatment based on the mRNA technology behind Covid-19 vaccines met its goals in treating melanoma, potentially marking a major advancement in cancer care.
https://www.facebook.com/share/r/19V9exqb9y/